cbdMD (YCBD) Depreciation & Amortization (CF) (2016 - 2025)
cbdMD (YCBD) reported Depreciation & Amortization (CF) of $54160.0 for Q4 2025, down 49.26% on a YoY basis from $106740.0 in Q4 2024, and down 23.49% sequentially from $70788.0 in Q3 2025.
cbdMD (YCBD) Depreciation & Amortization (CF) (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $54160.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 49.26% year-over-year to $54160.0; the trailing twelve-month figure through Dec 2025 stood at $308483.0 (down 31.17% YoY), and the FY2025 full-year result was $361063.0, down 20.18% from the prior year.
- Depreciation & Amortization (CF) slipped to $54160.0 in Q4 2025, from $70788.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $340701.0 in Q4 2021 to a low of $54160.0 in Q4 2025.
- A 5-year average of $158186.4 and a median of $114912.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 46.44% in 2021 and sank 70.62% in 2022, its largest moves.
- Tracing YCBD's Depreciation & Amortization (CF) over 5 years: stood at $340701.0 in 2021, then slumped by 70.62% to $100112.0 in 2022, then advanced by 10.74% to $110864.0 in 2023, then slipped by 3.72% to $106740.0 in 2024, then plunged by 49.26% to $54160.0 in 2025.
- Business Quant data shows YCBD's Depreciation & Amortization (CF) at $54160.0 in Q4 2025, $70788.0 in Q3 2025, and $88906.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 54,160.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54,160.00 |
| Dec 31, 2025 | 54,160.00 |
| Sep 30, 2025 | 70,788.00 |
| Sep 30, 2025 | 70,788.00 |
| Jun 30, 2025 | 88,906.00 |
| Jun 30, 2025 | 88,906.00 |
| Mar 31, 2025 | 94,629.00 |
| Mar 31, 2025 | 94,629.00 |
| Dec 31, 2024 | 106,740.00 |
| Dec 31, 2024 | 106,740.00 |
| Sep 30, 2024 | 108,799.00 |
| Sep 30, 2024 | 108,799.00 |
| Jun 30, 2024 | 114,912.00 |
| Jun 30, 2024 | 114,912.00 |
| Mar 31, 2024 | 117,751.00 |
| Mar 31, 2024 | 117,751.00 |
| Dec 31, 2023 | 110,864.00 |
| Dec 31, 2023 | 110,864.00 |
| Sep 30, 2023 | 103,554.00 |
| Sep 30, 2023 | 103,554.00 |